- “Who gets stuck with the bill?” (Chicago Tribune)
- “Results from a Phase 2 Study of ABRAXANE® In Combination With Carboplatin Show Clinical Activity in the First Line Treatment of Patients with Advanced Non-Small Cell Lung Cancer” (Press release issued by Abraxis BioScience, Business Wire)
- “Boehringer to start new Phase III study of Tovok” (Reuters)
- “Astra, Bristol price diabetes drug same as Merck’s” (Reuters)
- “Icagen Rallies, Genzyme Slides On FDA Updates” (Wall Street Journal)
- “Oncothyreon Shows Long-Lasting Effect” (Seattle Post Intelligencer)
- “Biogen may fight J&J-Elan deal” (FierceBiotech)
- “Merck vaccines chief to step down November 1” (Reuters)
- “Perrigo Announces FDA Approval for Generic Version of NASACORT(R) AQ” (Press release issued by Perrigo, EarthTimes)
- “For Generic Vancocin, An Advisory Committee Role Reversal” (The Pink Sheet)
- “Medtronic To Pay Abbott $400M To Settle Stent Suits” (Wall Street Journal)
- “Good quarter for Takeda but strong yen takes its toll” (PharmaTimes)
- “U.S. House panel backs 12-year biotech drug shelter” (Reuters)
- “MAP Pharma posts narrower-than-expected Q2 loss” (Reuters)
- “AstraZeneca flat after expected drug okay” (Reuters)
- “AstraZeneca and Bristol-Myers Squibb get US approval of ONGLYZA for type 2 diabetes in adults” (Press release issued by Bristol-Myers Squibb, TradingMarkets)
- “Roche’s Avastin gets U.S. nod for kidney cancer” (Reuters)
- “FDA: Teva blocked from selling animal drugs” (Reuters)
- “F.D.A. Rejects Savient’s Gout Drug” (The New York Times)
- “FDA lifts partial clinical hold on epilepsy drug: Icagen” (Reuters)
- “FDA approves new use for antipsychotic Invega” (BusinessWeek)
- “First Gene Test for Side Effects May Revive Novartis Pain Pill” (Bloomberg)
- “Swiss Nycomed to buy Sanofi local portfolio” (Reuters)
- “Vical and Teva Establish Sales and Marketing Agreement for Allovectin-7(r) in Israel” (Press release issued by Vical Inc., Globe Newswire)
- “OSI says Tarceva extends lung cancer survival” (Reuters)
- “Experts find new targets to stop breast cancer” (Reuters)
THE LATEST WORD
Top Industry Stories – August 3, 2009
Posted on August 3rd, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics